Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket

Shares of Nxu, Inc. NXU rose sharply in pre-market trading after the company signed a letter of intent outlining investment in Lynx Motors.

Nxu, shares rose 42.1% to $0.0278 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• XBP Europe Holdings, Inc. XBP shares rose 150% to $14.20 in pre-market trading after declining around 20% on Wednesday.
• Hanryu Holdings, Inc. HRYU gained 34.8% to $1.47 in pre-market trading after jumping 28% on Wednesday.
• Meiwu Technology Company Limited WNW shares gained 21.1% to $0.0850 in pre-market trading.
• Codexis, Inc. CDXS shares surged 20.5% to $2.52 in pre-market trading. Codexis announced achievement of gram-scale synthesis with its ECO Synthesis platform.
• Esperion Therapeutics, Inc. ESPR shares climbed 15.2% to $1.74 in pre-market trading. Esperion said that the FDA updated LDL-C lowering indication for NEXLETOL (bempedoic acid) tablet and NEXLIZET (bempedoic acid and ezetimibe) tablet.
• Blue Water Biotech, Inc. BWV shares rose 14.9% to $0.3109 in pre-market trading after gaining 7% on Wednesday.
• Ekso Bionics Holdings, Inc. EKSO gained 14.6% to $1.33 in pre-market trading after falling 15% on Wednesday.
• Nubia Brand International Corp. NUBI rose 13.8% to $11.00 in pre-market trading after falling 9% on Wednesday.
• Sonoma Pharmaceuticals, Inc. SNOA shares gained 11.1% to $0.19 in pre-market trading.

Losers

• Amtech Systems, Inc. ASYS shares fell 26.4% to $4.41 in pre-market trading after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.
• Regis Corporation RGS shares fell 22.6% to $7.20 in pre-market trading. NYSE will begin delisting proceedings against Regis Corp.
• Cepton, Inc. CPTN fell 22.4% to $3.08 in pre-market trading after the company posted downbeat third-quarter sales and issued weak FY23 revenue forecast.
• NextPlay Technologies, Inc. NXTP shares fell 18.4% to $1.28 in pre-market trading after jumping 68% on Wednesday.
• Ocular Therapeutix, Inc. OCUL shares fell 18% to $3.23 in pre-market trading. Ocular Therapeutix priced its public offering of 30.8 million common share stock at $3.25 per share for gross proceeds of $100.1 million.
• Applied UV, Inc. AUVI shares fell 14.5% to $1.59 in pre-market trading after declining around 10% on Wednesday. Applied UV teamed with Silver Cross Hospital in New Lenox, Illinois for the implementation of the groundbreaking Far-UVC Puro Protect 222nm fixtures in the hospital's Sterile Processing Department (SPD).
• Shattuck Labs, Inc. STTK fell 13.5% to $4.20 in pre-market after gaining 130% on Wednesday. Shattuck Labs announced initial topline dose-expansion data from its ongoing Phase 1A/B trial of SL-172154 in combination with Azacitidine (AZA) in frontline high-risk myelodysplastic syndromes (HR-MDS) and TP53 mutant (TP53m) acute myeloid leukemia (AML) patients.
• Phio Pharmaceuticals Corp. PHIO fell 11.8% to $0.6873 in pre-market trading after declining 9% on Wednesday. Phio Pharmaceuticals recently announced it will exercise warrants for $2.8 million in gross proceeds.
• Intensity Therapeutics, Inc. INTS shares fell 8.4% to $9.05 in pre-market trading after jumping 22% on Wednesday. Intensity Therapeutics recently named Joseph Talamo as CFO.
• Adobe Inc. ADBE fell 6.1% to $586.38 in pre-market trading. Adobe posted upbeat earnings for its fourth quarter, but issued weak sales forecast for full-year 2024.

Now Read This: Lennar Gears Up For Q4 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts